A Mobile Device App to Reduce Medication Errors and Time to Drug Delivery During Pediatric Cardiopulmonary

Johan N Siebert1, Frederic Ehrler2, Christian Lovis2

  • 1Department of Pediatric Emergency Medicine, Geneva Children's Hospital, University Hospitals of Geneva, Geneva, Switzerland.

JMIR Research Protocols
|August 24, 2017
PubMed

Insights

This study evaluated the Pediatric Accurate Medication in Emergency Situations (PedAMINES) mobile app during pediatric resuscitation. The app significantly reduced medication dosage errors and preparation times compared to conventional methods, improving pediatric emergency care.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Informatics
  • Medication Safety

Background:

  • Pediatric cardiopulmonary resuscitation (CPR) involves complex vasoactive drug preparation, increasing medication error risk.
  • A mobile app, Pediatric Accurate Medication in Emergency Situations (PedAMINES), was developed to streamline drug preparation and delivery.
  • Previous trials showed PedAMINES reduced medication errors from 70% to 0%.

Purpose of the Study:

  • To determine if PedAMINES reduces medication dosage errors during pediatric CPR in diverse hospital settings.
  • To assess the impact of PedAMINES on time to drug preparation (TDP) and time to drug delivery (TDD).

Main Methods:

  • A multicenter, prospective, randomized controlled crossover trial involving 120 nurses in simulated pediatric CPR scenarios.
  • Comparison of PedAMINES against conventional infusion rate tables for preparing dopamine and norepinephrine infusions.
  • Outcomes measured: medication dosage error rate (primary), TDP, TDD, and participant stress levels.

Main Results:

  • Data analysis and enrollment commenced in March 2017, with results anticipated for publication in mid-2018.
  • Results will be reported following CONSORT-EHEALTH and healthcare simulation research guidelines.

Conclusions:

  • This clinical trial protocol assesses a mobile app's effectiveness in reducing medication errors and improving efficiency in pediatric resuscitation.
  • The study's findings are expected to significantly impact and enhance pediatric emergency care practices due to limited existing research.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
373
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
35
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
44
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
983
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353